Rapid Molecular Subtyping for Precision Oncology

New AI 'Hetairos' Diagnoses Brain Tumors in Minutes

Researchers at the DKFZ unveil an AI tool that identifies over 100 molecular tumor subtypes with high speed and accuracy.

By Avantgarde News Desk··1 min read
A medical computer screen in a lab displaying a brain scan with tumor analysis data and a progress bar showing completion.

A medical computer screen in a lab displaying a brain scan with tumor analysis data and a progress bar showing completion.

Photo: Avantgarde News

Researchers at the German Cancer Research Center (DKFZ) developed a new AI system named Hetairos [1]. The tool identifies over 100 molecular subtypes of brain and spinal cord tumors within minutes [1][2]. This represents a significant advancement over current diagnostic methods [3].

Traditional molecular testing usually requires up to two weeks to produce results [2]. Hetairos can complete the same analysis in approximately 12 minutes [2]. In clinical tests, the AI significantly outperformed human pathologists in both diagnostic speed and accuracy [1][3].

This speed allows doctors to start targeted treatments much earlier in the care process [2]. The system provides a level of detail previously difficult to achieve in such a short timeframe [1]. This breakthrough could lead to improved outcomes for patients with central nervous system tumors [2][3].

Editorial notes

Transparency note

AI assisted drafting. Human edited and reviewed.

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Low

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Topics

Get the weekly briefing

Weekly brief with top stories and market-moving news.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Avantgarde News Desk covers rapid molecular subtyping for precision oncology and editorial analysis for Avantgarde News.